Rare diseases
Investigational molecules
Locations
Salvatorstrasse 7, Frauenland, 97074 Wuerzburg, Germany
Klinikum Wuerzburg Mitte gGmbH in Wuerzburg, Germany specialises in clinical trials of conditions such as Non-small cell lung cancer, Myasthenia gravis, Non-small cell lung cancer metastatic, K-ras gene mutation, and other specialisations. This site conducts important research.
At Klinikum Wuerzburg Mitte gGmbH, investigators are studying metastatic non‑small cell lung cancer with the aim of testing new targeted agents and immunotherapy combinations to improve survival outcomes.
Results are expected to shape future lung‑cancer treatment guidelines and provide new options for patients with advanced disease.
The research team is also dedicated to advancing care for multiple sclerosis, focusing on the long‑term safety and tolerability of oral therapies for both relapsing and progressive forms of the disease.
Findings will help clinicians choose safer, more effective strategies for managing chronic nervous‑system disorders.
Clinical trials currently enrolling participants at this site.
GermanyPhase III Randomized Study of Rilvegostomig vs. Pembrolizumab with Platinum-based Chemotherapy in PD-L1 Expressing Metastatic Squamous NSCLC
GermanyStudy comparing rilvegostomig plus chemotherapy versus pembrolizumab plus chemotherapy for first-line treatment in patients with metastatic non-squamous lung cancer with PD-L1 expression
GermanyAdjuvant Therapy with RO7435846 (divarasib) versus Pembrolizumab or Nivolumab or Observation in Patients After Surgery for Stage II‑III KRAS G12C NSCLC
GermanyA Study of Depemokimab Compared to Placebo in Adults with Chronic Obstructive Pulmonary Disease and Type 2 Inflammation
GermanyA Study of IMVT-1402 in Adults with Chronic Inflammatory Demyelinating Polyneuropathy to Prevent Disease Relapse
GermanyStudy of IMVT-1402 in Adults with Mild to Severe Generalized Myasthenia Gravis
GermanyStudy of BMS-986368 to treat muscle stiffness in people with Multiple Sclerosis
GermanyStudy of Amivantamab, Lazertinib, and Pemetrexed for Patients with Advanced or Metastatic Solid Tumors, Including EGFR-Mutated Non-Small Cell Lung Cancer
GermanyStudy on Long-Term Safety of Tolebrutinib and Teriflunomide for Patients with Multiple Sclerosis
GermanyStudy of divarasib and pembrolizumab compared to standard chemotherapy in previously untreated KRAS G12C-mutated advanced non-small cell lung cancer
GermanyStudy on Datopotamab Deruxtecan and Rilvegostomig for Stage I Non-Small Cell Lung Cancer Patients with ctDNA-Positive or High-Risk Features
GermanyGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
